Search research articles
Contact Us
Filters
Showing results (251-260 of 316) with videos related to
Page
of 32
Sort By:
Cancer Biology & Therapy
|
January 30, 2013
Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
Nishant Gandhi, Aaron T Wild, Sivarajan T Chettiar, et al.
Anticancer Research
|
May 31, 2015
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients
Gian-Carlo Mattiucci, Massimo Falconi, Ruud G P M VAN Stiphout, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 20, 2012
Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors
Shinichi Yachida, Catherine M White, Yoshiki Naito, et al.
Advances in Radiation Oncology
|
June 13, 2020
IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer
Shalini Moningi, Jaffer A Ajani, Brian D Badgwell, et al.
Annals of Surgery
|
May 29, 2015
Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical Management
Vicente Valero, Tyler J Saunders, Jin He, et al.
Oncology (Williston Park, N.Y.)
|
October 18, 2014
ACR Appropriateness Criteria® rectal cancer: metastatic disease at presentation
Karyn A Goodman, Sarah A Milgrom, Joseph M Herman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 23, 2014
Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy
Avani S Dholakia, Muhammad Chaudhry, Jeffrey P Leal, et al.
Annals of Surgical Oncology
|
February 7, 2022
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
Colin S Hill, Lauren M Rosati, Chen Hu, et al.
Cancers
|
December 9, 2020
Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study
Mohamed Zaid, Lauren Widmann, Annie Dai, et al.
American Journal of Clinical Oncology
|
September 16, 2015
ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer
Suzanne Russo, A William Blackstock, Joseph M Herman, et al.
Page
of 32
Search research articles
Search
Showing results (251-260 of 316) with videos related to
Sort By:
Page
of 32
Cancer Biology & Therapy
|
January 30, 2013
Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
Nishant Gandhi, Aaron T Wild, Sivarajan T Chettiar, et al.
Anticancer Research
|
May 31, 2015
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients
Gian-Carlo Mattiucci, Massimo Falconi, Ruud G P M VAN Stiphout, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 20, 2012
Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors
Shinichi Yachida, Catherine M White, Yoshiki Naito, et al.
Advances in Radiation Oncology
|
June 13, 2020
IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer
Shalini Moningi, Jaffer A Ajani, Brian D Badgwell, et al.
Annals of Surgery
|
May 29, 2015
Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical Management
Vicente Valero, Tyler J Saunders, Jin He, et al.
Oncology (Williston Park, N.Y.)
|
October 18, 2014
ACR Appropriateness Criteria® rectal cancer: metastatic disease at presentation
Karyn A Goodman, Sarah A Milgrom, Joseph M Herman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 23, 2014
Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy
Avani S Dholakia, Muhammad Chaudhry, Jeffrey P Leal, et al.
Annals of Surgical Oncology
|
February 7, 2022
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
Colin S Hill, Lauren M Rosati, Chen Hu, et al.
Cancers
|
December 9, 2020
Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study
Mohamed Zaid, Lauren Widmann, Annie Dai, et al.
American Journal of Clinical Oncology
|
September 16, 2015
ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer
Suzanne Russo, A William Blackstock, Joseph M Herman, et al.
Page
of 32